RECOMBINANT APYRASE PROTEIN FOR USE IN THE TREATMENT OF AN ISCHEMIC EVENT AT A DOSE OF 40-240 MG

CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION

ENHANCED COMPOSITION FOR TREATMENT OF DENGUE FEVER

Salicylate Compound Composition

COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN

SUSTAINED RELEASE COMPOSITION COMPRISING AN ETHYLCELLULOSE

PIPERIDINE UREA DERIVATIVES FOR CANCER THERAPY

PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND ACETYLSALICYLIC ACID, PROCESS FOR PREPARING THE SAME, AND USES THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING TICAGRELOR AND ACETYLSALICYLIC ACID, PROCESS FOR PREPARING THE SAME, AND USES THEREOF

METAL OXIDE BIOLOGICAL IONOMER AND METHODS

ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES

APPLICATION OF CARBASALATE CALCIUM IN PREPARING DRUG FOR TREATMENT OF HYDROCEPHALUS

USE OF MILVEXIAN FOR TREATING OR PREVENTING ISCHEMIC STROKE

COMPOSITIONS OF COPPER COMPLEXES

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

PHARMACEUTICAL COMPOSITION AND METHODS FOR MODULATING INFLAMMATION AND OXIDATIVE STRESS

Methylene Blue COVID-19 Composition

ORAL PAIN RELIEVER COMPOSITION, PHARMACEUTICAL FORMULATION, AND PROCESS FOR MAKING COMPOSITION AND FORMULATION INCLUDING CANNABIDIOL ISOLATE WITH SELECT ACTIVE INGREDIENTS

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

DRUG CONDITIONING REGIMEN FOR SICKLE CELL DISEASE

AN INHALER COMPRISING A RETENTION ELEMENT

COMPOSITION OF MALUS NIEDZWETZKYANA DIECK AND PRUNUS CERASIFERA EHRHART AND USE THEREOF IN TERMS OF RESISTING ATHEROSCLEROSIS

PHARMACEUTICAL COMPOSITION COMPRISING ACETYLSALICYLIC ACID AND PROTON PUMP INHIBITOR

THERAPEUTIC METHODS

TREATMENT OF SPINAL MUSCULAR ATROPHY BY INDUCING HEAT SHOCK RESPONSE

Use of Baby Aspirin with Diphenhydramine or other Sleep Aids

Biopolymer Formulations for Drug Delivery

VALPROIC ACID FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION

HIGHLY TRANSPARENT WATER CONTINUOUS DENSE NANOLIPID FLUID (DNLF) DISPERSIONS AND METHOD OF PREPARATION USING A TWIN SCREW EXTRUDER

NEW USE

NEW USE

METHODS FOR ADMINISTERING FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS TO SUBJECTS TREATED WITH A FACTOR XI INHIBITOR

METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT

SYSTEMS AND METHODS TO IDENTIFY AND TREAT SUBJECTS AT RISK FOR OBSTETRICAL COMPLICATIONS

USE OF DELTA-TOCOTRIENOL TO REDUCE THE PROGRESSION OF A NEOPLASM TO A CANCER

ENDOVASCULAR INTERVENTIONS IN NEUROVASCULAR ANATOMY

MEDICATION TO ALLEVIATE NAUSEA WITH OR WITHOUT VOMITING, VERTIGO, AND PAIN

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS

COMPOSITIONS AND METHODS FOR TREATMENT OF NAFLD AND NASH AND RELATED DYSLIPIDEMIAS

METHODS FOR TREATING NEUROBLASTOMA

Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Variants And Uses Thereof

Device And Method For Stimulating The Meibomian Glands Of The Eyelid

ACETYL SALICYLIC ACID COMPOSITION FOR INTRAVENOUS ADMINISTRATION, ITS STORAGE, PRODUCTION AND USE

PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES WITH HIGH PENETRATION PRODRUGS OF ASPIRIN AND OTHER NSAIDS

COMPOSITIONS OF ASPIRIN AND KETAMINE

SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE

Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

METHODS FOR SELECTING A CANCER PATIENT FOR TREATMENT

Improved synthesis of lysine acetylsalicylate - Glycine particles

METHOD OF TREATING HYPOGONADISM IN MEN

COMPOSITION AND METHOD OF TREATING HYPOGONADISM IN MEN

METHODS AND MATERIALS FOR TREATING HEART ATTACK

SELF-EMULSIFYING OIL-IN-WATER MICROEMULSION OR NANOEMULSION, AND EMULSIFYING COMPOSITION

DEVICE AND METHOD FOR STIMULATING AND SCRUBBING THE MEIBOMIAN GLANDS OF THE EYELID

PARTICLE-BASED MULTI-LAYER THERAPEUTIC DELIVERY DEVICE AND METHOD

METHODS OF DIAGNOSING AND TREATING OSTEOARTHRITIS

COMBINATIONS OF ANTI-INFLAMMATORY AGENTS FOR TREATING ACUTE ORGAN FAILURE, ARDS, ORGANS FOR TRANSPLANTATION OR DISEASES CAUSED BY AN AIRWAY-TARGETING VIRUS

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR

SUSTAINED RELEASE COMPOSITION COMPRISING A METHYLCELLULOSE

METHODS FOR SELECTING AN INTRACRANIAL ATHEROSCLEROTIC DISEASE PATIENT FOR TREATMENT

NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS

METHODS FOR TREATING HYPERVIRULENT KLEBSIELLA PNEUMONIAE INFECTION

METHODS OF PREVENTING SYMPTOMATIC ISCHEMIC STROKE

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED DISORDERS

Solid Solution Compositions and Use in Chronic Inflammation

Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases

PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF

NOVEL COMPOSITION

REMEDIATION OF ALL DISEASES CAUSED BY RADIATION RELATED REACTIVE ION SPECIES ARE ALL CORRECTABLE BY H2S - SO2 GENERATED BY FDA-STS SODIUM THIOSULFATE, NA2S203

TWO-COMPONENT COMPOSITION

Solid Solution Compositions and Use in Severe Pain

Dental enamel compositions with anti-inflammatory agents

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

METHODS FOR TREATING NEUROBLASTOMA

VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY

THERAPEUTIC USES OF DULAGLUTIDE

TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FMO3/TMAO PATHWAY

NOVEL COMPOSITION

Methods and Compositions to Inhibit Symptoms Associated with Viral Upper Respiratory Tract Infections

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NEUROTROPHIC AND NEUROPROTECTIVE COMPOSITIONS

COMPOSITIONS AND METHODS OF MAKING COCRYSTALS USING DIELECTRIC HEATING WITH DISPERSIVE AND DISTRIBUTIVE MIXING

COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS

Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

METHODS AND COMPOSITIONS FOR TREATING PERICARDITIS

Methods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of Anti-Inflammatory Nutraceuticals

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES

METHODS AND SYSTEMS FOR DETERMINING RISK OF A PREGNANCY COMPLICATION OCCURRING

COMPOSITIONS FOR TREATING GASTROINTESTINAL ADENOCARCINOMAS BY ALTERING THE TUMOR MICROENVIRONMENT

TREATMENTS OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

METHOD FOR TREATING ACUTE ISCHEMIC STROKE

COMPOSITIONS OF ASPIRIN AND KETAMINE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF MICROBIAL INFECTIOUS DISEASES AND ASSOCIATED INFLAMMATORY DISORDERS AND FOR THE TREATMENT AND PROPHYLAXIS OF AGING AND ASSOCIATED DISEASES

Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin

DELIVERY SYSTEMS

PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME

TOPICAL COMPOSITIONS AND METHODS FOR TREATING PAIN

Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and use

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS

DEUTERATED RUC-4

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION

CANCER THERAPEUTIC

Spirolactone compounds

CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND PSILOCYBIN

Systems and methods to identify and treat subjects at risk for obstetrical complications

METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING

DELIVERY SYSTEMS

SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR

Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof

DRY POWDER FORMULATIONS FOR INHALATION

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

DELIVERY SYSTEMS

Dental enamel compositions with anti-inflammatory agents

ENDOVASCULAR INTERVENTIONS IN NEUROVASCULAR ANATOMY

DETERIMINING RISK OF SPONTANEOUS CORONARY ARTERY DISSECTION AND MYOCARDIAL INFARCTION AND SYSEMS AND METHODS OF USE THEREOF

D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND SCREENING METHOD OF D-SERINE TRANSPORTER PROTEIN

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

Dry powder formulations for inhalation

PHARMACEUTICAL COMPOSITION

COMPOSITIONS AND METHODS FOR THE TREATMENT OF THREATENED RESPIRATORY FAILURE CAUSED BY CORONAVIRUS INFECTION AND DISEASE

COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE

TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIA

CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19

NOVEL PROCESSES FOR THE PREPARATION OF RAPID MELT GRANULES

RED BLOOD CELL-DERIVED VESICLE

SUBLINGUAL FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID WITH CITRIC ACID, SODIUM BICARBONATE ,AND L-THEANINE FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION

SUBLINGUAL FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID WITH CITRIC ACID, SODIUM BICARBONATE, AND L-THEANINE FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION

Partially pre-gelatinized cassava starch as pharmaceutical excipient

MEDICAL USE OF ICARITIN

USE OF DOXYCYCLINE, RESVERATROL, IVERMECTIN, AND RELATED CHEMICALLY MODIFIED COMPOUNDS TO TREAT OR PREVENT VIRAL INFECTIONS

DEVICE FOR INHALING POWDERED ACETYLSALICYCLIC ACID AND RELATIVE USE THEREOF

ORAL ADMINISTRATION OF KETAMINE

CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF

USE OF ADEFOVIR DIPIVOXIL AND STRUCTURAL ANALOG THEREOF FOR TREATING PSEUDORABIES VIRUS

Antimicrobial Composition

Compositions and methods for treating lysosomal disorders

Cyclooxygenase-2 Inhibition for the Treatment of SAA-high Asthma

In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)

CHEMOTHERAPY FOR GLIOMA THROUGH NEURONAL CONVERSION

Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation

DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS

Hair removal admixture with wax, antiseptic, analgesic, moisturizing oil, and chemical depilatory: Hair removal chemical composite/creamy wax.

ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE

TREATMENT OF MODERATE TO SEVERE INFLUENZA

METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET

COMPOSITIONS FOR ORAL MICROADHESIVE DOSAGE FORMS

COMPOSITIONS AND METHODS USING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

ANTISEPTIC AND/OR ANTI-INFLAMMATORY GEL FOR TREATMENT OF ORAL CAVITY DISEASES COMPRISING POLYVINYL ALCOHOL AND POLYACIDS

Devices and methods for treating ear pain

Method for the Reduction of Dangerous Blood Sugar Levels

Compositions of hydroxy acids with salicylic acid and uses therefore

Nucleic acid nanocarrier drug and preparation method thereof, pharmaceutical composition and application thereof

Two-component composition

USE OF DELTA-TOCOTRIENOL IN TH PREVENTION OF CANCER AND CANCER RECURRENCE

Oral administration of ketamine

PYRROLE AMIDE COMPOUND AND USE THEREOF

LIPOSOMAL SUSTAINED-RELEASE COMPOSITIONS CONTAINING A THERAPEUTIC DRUG AND USE THEREOF

Therapeutic uses of dulaglutide

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

Effervescent composition and method of making it

MELOXICAM CO-CRYSTAL COMPOSITIONS

DELIVERY SYSTEMS FOR RELEASE OF ACTIVE COMPOUNDS

Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

CAPSULE WITH INTERNAL DIAPHRAGM FOR IMPROVED BIOAVAILABILITY

Compositions and kits useful for treatment of respiratory illness

Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof

Dental enamel compositions with anti-inflammatory agents

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

COMPOSITIONS AND METHODS FOR TREATMENT OF A CORONAVIRUS DISEASE (COVID-19) INFECTION

METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN

Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields

Solid solution compositions and use in severe pain

Composition for the treatment of COVID-19

METHODS OF TREATING COVID-19 AND COMPOSITIONS THEREFOR

METHOD OF TREATING PATIENTS WITH A FACTOR Xa INHIBITOR, ASPIRIN, AND VERAPAMIL

Solid solution compositions comprising cannabidiols

METHOD OF USING COMPOSITION FOR TREATMENT OF VEISALGIA

A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE

Pharmaceutical Combinations for the Treatment of Cancer

Immediate release abuse-deterrent granulated dosage forms

COMPOUNDS FOR PRENATAL TREATMENT COMPRISIING A NATAL VITAMIN AND ASPIRIN AND METHOD FOR MAKING AND USING THE SAME

SUSTAINED RELEASE COMPOSITION COMPRISING AN ETHYLCELLULOSE

Method of Treatment and Pharmaceutical Composition for Morning Hypertension

A SUSTAINED RELEASE COMPOSITION COMPRISING A METHYLCELLULOSE

DRY POWDER FORMULATIONS FOR INHALATION

Solid solution compositions and use in chronic inflammation

Compositions and kits useful for treatment of respiratory illness

DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

COMBINATION TABLET WITH CHEWABLE OUTER LAYER

Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Nasal Delivery of Low-Dose Aspirin for the Treatment of Neurodegenerative and Lysosomal Storage Diseases

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

METHODS FOR TREATING NEUROBLASTOMA

Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and use

HEALTH MANAGEMENT COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

Deuterated RUC-4

Softgels with solid or gel-like polymeric fill matrix

Compositions And Methods Useful For Treatment Of Respiratory Illness

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

Endovascular interventions in neurovascular anatomy

Therapy for the Coronavirus, COVID-19 Pandemic

NLRP3 inflammasome inhibitors

SYSTEMS AND METHODS FOR DELIVERY OF DRUGS AND OTHER SUBSTANCES COMPRISING DEEP EUTECTIC SOLVENTS

COPOLYMER COMPOSITION FOR COATING AND ADHESIVE APPLICATIONS

Biofouling prevention of wearable sensors and methods of use and calibration related thereto

PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF

SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS FOR TOPICAL INTESTINAL DELIVERY OF VITAMIN B3

METHODS AND SYSTEMS FOR DETERMINING RISK OF A PREGNANCY COMPLICATION OCCURRING

Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines

Prenatal Supplement Formulation and Method of Administration

METHODS FOR TREATING AND PREVENTING NOCICEPTIVE PAIN

Solid solution compositions and use in chronic inflammation

Treatments of non-alcoholic steatohepatitis (NASH)

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

PHENYL-SUBSTITUTED DIHYDRONAPHTHYRIDINE COMPOUND AND USE THEREOF

USE OF DELTA-TOCOTRIENOL FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATING OCULAR INFLAMMATION AND OCULAR SCARRING

Treating and preventing disease with TMA and TMAO lowering agents

Dry powder formulations for inhalation

METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS

GABA-A ANTAGONISTS FOR TREATING SUBSTANCE WITHDRAWAL DISORDERS

ENHANCEMENT OF DELIVERY OF LIPOPHILIC ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

Spirolactone compounds

CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERS

METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS

Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions

Vasoprotective and cardioprotective antidiabetic therapy

BIOMARKERS AND USES THEREOF

METHOD OF TREATING PATIENTS WITH A FACTOR Xa INHIBITOR, ASPIRIN, AND VERAPAMIL

Compositions and Methods for Preventing or Treating Nephrolithiasis

COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS

Two component compositions

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

Dental enamel compositions with anti-inflammatory agents

REDUCING THE RISK OF CARDIOVASCULAR EVENTS

ACTIVATED LYMPHOCYTIC CELLS AND METHODS OF USING THE SAME TO TREAT CANCER AND INFECTIOUS CONDITIONS

ANTISEPTIC AND/OR ANTI-INFLAMMATORY GEL FOR TREATMENT OF ORAL CAVITY DISEASES COMPRISING POLYVINYL ALCOHOL AND POLYACIDS

Delivery systems

COMBINED COLLAGEN NSAID ANALGESIC DOSAGE REGIMEN

Unit aerosol doses for anticoagulation

METHODS AND COMPOSITIONS UTILIZING RRx-001 FOR RADIOPROTECTION

Use of combination or composition of Radix et Rhizoma Notoginseng and aspirin

Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture

Device And Method For Stimulating The Meibomian Glands Of The Eyelid

FOOD AND BEVERAGE COMPOSITIONS COMPRISING PDE5 INHIBITORS

Solid solution compositions and use in severe pain

Compositions comprising acetylsalicylic acid and a phosphate salt

CANCER TREATMENT AND METASTASIS INHIBITION USING AN ANTI-CANCER STEM CELL AGENT IN COMBINATION WITH A NEU1 SIALIDASE INHIBITOR OR A CYTOKINE INHIBITOR AFTER PRIMARY CANCER TREATMENT

Solid solution compositions and use in cardiovascular disease

Methods and compositions to inhibit symptoms associated with viral upper respiratory tract infections

Solid solution compositions and use in chronic inflammation

Compositions and kits useful for treatment of respiratory illness

Piezo type mechanosensitive ion channel component 1 (PIEZO1) variants and uses thereof

ASPIRIN FORMULATION FOR INCREASED EFFICACY

Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment

Methods and Compositions Useful for Treating Cancer

SUSPENSIONS OF ENCAPSULATED PHARMACEUTICALS AND METHODS OF MAKING AND USING THE SAME

PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE

PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same

Delayed release drug formulation

USE OF RIBOSE IN FIRST RESPONSE TO ACUTE MYOCARDIAL INFARCTION

Solid solution compositions and use in chronic inflammation

Treating and preventing disease with TMA and TMAO lowering agents

CANCER THERAPEUTIC

In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid

THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANNEXIN A5

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION

Compositions and methods for treating multiple sclerosis

Immediate release abuse-deterrent granulated dosage forms

Thromboxane receptor antagonists in AERD/asthma

SACCHARIDE-BASED, ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS

Drug eluting matrix on analyte indicator

PECTIN GUMMY COMPOSTION AND METHODS OF MAKING AND USING THEREOF

GELATIN GUMMY COMPOSTION AND METHODS OF MAKING AND USING THEREOF

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR

Compositions Comprising Cancer Drug-Fatty Acid Conjugates

Dry powder formulations for inhalation

METHODS FOR DIAGNOSING AND TREATING CACHEXIA

Treating disease and promoting weight loss by inhibiting the TMA/FMO3/TMAO pathway

EMERGENCY MEDICATION STORAGE DEVICE FOR CARDIAC CHEST PAIN

AQUEOUS DRUG DELIVERY SYSTEM

Method of treating patients with a factor Xa inhibitor, aspirin, and verapamil

NON-PRESCRIPTION MOTION SICKNESS MEDICATION CONTAINING AN ANALGESIC, AN H2 BLOCKER, AND AT LEAST ONE ANTACID

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

SUBLINGUAL FORMULATION WITH WATER-SOLUBLE COCRYSTALS OF ACETYLSALICYLIC ACID WITH CITRIC ACID, SODIUM BICARBONATE, AND L-THEANINE FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION

Multifunctional aminoquinoline therapeutic agents

Glutarate compounds for treating ischemia-reperfusion injuries

METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS